![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Iridex Probe Earns CE Mark
Iridex Probe Earns CE Mark
March 20, 2018
Iridex’s G-Probe Illuminate was cleared for marketing in Europe, offering both transillumination and laser fiber for targeted transscleral cyclophotocoagulation (CPC).
It is the third probe by the company that is powered by the CYCLO G6 glaucoma laser system, and features built-in transillumination that optimizes the probe’s placement and therapeutic outcomes.
The device helps physicians deliver more targeted laser treatment.
Upcoming Events
-
21Oct